logo
  

Aegerion Pharmaceuticals Inc. (AEGR) Has Dropped To A New Low After Q1 Report

Aegerion Pharmaceuticals Inc. (AEGR) reported a first quarter non-GAAP loss of $0.25 per share after the bell Tuesday, compared to the loss of $0.51 a year ago.

Aegerion Pharmaceuticals gapped open sharply lower Wednesday and is now down 9.82 at $34.34 on above average volume. The stock has plummeted to a new low for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.

All eyes were on the U.S. Federal Reserve this week as the bank announced its latest policy decision. Find out the signals given out by Chair Jerome Powell regarding the future path of interest rates. Some key data on the U.S. private sector economy were also released. Other main news included the flash estimates of first quarter GDP from Eurozone. Elsewhere, the Paris-based think tank OECD released its latest round of macroeconomic projections for the global economy.

View More Videos
Follow RTT